v3.26.3
Stockholders’ Deficit
12 Months Ended
Jun. 30, 2026
Stockholders’ Deficit [Abstract]  
Stockholders’ deficit

Note 13 — Stockholders’ deficit

 

Common stock 

 

As of June 30, 2026 and 2025, the Company has 50,000,000 authorized shares of common stock, par value $0.0001 per share. As of June 30, 2026 and 2025, there are 7,041,192 and 6,780,597 shares of common stock outstanding, respectively.

 

Issuance of common stock upon completion of the Reverse Recapitalization

 

On September 26, 2024, upon the consummation of the business combination, the Company issued an aggregated total of 2,270,096 common stock to ACAC shareholders and its underwriter.

 

The following table presents the number of the Company’s common stock issued upon completion of the Reverse Recapitalization:

 

    Shares of
Common
 
    Stock  
ACAC’s common stock outstanding prior to Reverse Recapitalization     3,971,634  
Less: redemption of ACAC’s common stock     (1,744,663 )
Common stock issued to underwriter     43,125  
Total common stock issued upon completion of the Reverse Recapitalization     2,270,096  

 

Conversion of convertible promissory notes into common stock

 

On September 26, 2024, upon the consummation of the business combination, the Company issued an aggregated total of 1,696,668 common stock to the Old Foxx convertible notes holders.

 

Equity incentive plan  

 

On September 24, 2024, pursuant to the Equity Incentive Plan (the “EIP”), 1,454,019 shares of common stock, par value $0.0001 per share, of the Company were set aside and reserved for issuance of certain stock option award and certain restricted shares to certain of the Company’s employees and consultants. The EIP has a 4-year vesting schedule, of which, 25% will be vested after year 1 with the 1/16th of these shares will vest each quarter thereafter on the same day of the month as the grant date. The vesting of each RSU is subject to the employee’s continued employment and the consultant’s continued engagement through applicable vesting dates.

 

On November 5, 2024, the Company granted 707,860 restricted stock units (“RSUs”) to its employees, consultants, and independent directors under its EIP. These shares have a 4-year vesting schedule of which 25% will be vested after year 1 with the 1/16th of these shares will vest each quarter thereafter on the same day of the month as the grant date. The vesting of each RSU is subject to the employee’s continued employment and the consultant’s continued engagement through applicable vesting dates.

 

On January 22, 2025, the Company granted 19,149 RSUs to one of its independent directors pursuant to the EIP. These shares have a 4-year vesting schedule, of which 25% will be vested after year 1 with the 1/16th of these shares will vest each quarter thereafter on the same day of the month as the grant date. The vesting of each RSU is subject to the director’s continued employment through applicable vesting date.

 

On April 24, 2025, the Company cancelled 33,080 unvested RSUs previously granted to one of its consultants on November 5, 2024, due to termination of the consultant’s engagement.

 

On July 31, 2025, the Company cancelled 9,574 unvested RSUs previously granted to one of its employees on November 5, 2024, due to termination of the employment.

 

On November 4, 2025, two of the Company’s employees resigned from their position with the Company and the Company agreed to accelerate the vesting term for an immediate vesting for a total of 31,819 or approximately 50% of their unvested RSUs previously granted to them due to termination of their employment, resulting in an acceleration of $174,204 recorded in stock-based compensation during the six months ended December 31, 2025. A total of 31,817 or approximately 50% of their unvested RSUs previously granted to them were forfeited due to termination of their employment, resulting in a forfeiture $58,068 recorded in stock-based compensation during the six months ended December 31, 2025.

 

In May 2026, two of the Company’s employees elected to have 1,945 and 844 shares, respectively, withheld from their RSU awards upon vesting to satisfy their employee tax withholding obligations. Accordingly, the Company withheld an aggregate of 2,789 shares and settled the employees’ required tax withholding obligations using the fair value of such shares of $13,276, based on the Company’s stock price on the respective vesting date of $4.76 per share.

 

The RSUs are accounted for as equity awards and are measured at fair value based upon the grant date market value of the Company’s common stock. Compensation expense is recognized on a straight-line basis over the vesting service period of four years. Forfeitures are accounted for as they occur.

 

The following table presents the total stock-based compensation expenses included in each of the respective expense line items for the periods presented: 

 

    For the Years Ended  
    June 30,  
    2026     2025  
             
Selling expenses   $ 307,458     $ 175,332  
General and administrative expenses     690,393       448,511  
Research and development expenses     263,703       191,835  
Total stock-based compensation expenses   $ 1,261,554     $ 815,678  

 

The following table summarizes the activity for all restricted stock units granted for the years ended Juen 30, 2026 and 2025:

 

    Shares     Weight
average
grant date
fair value
    Total fair
value
    Weighted
average  
remaining
contractual
term
(in years)
 
Unvested at July 1, 2024     -     $ -     $ -       -  
Granted     727,009       7.21       5,243,400       4.00  
Vested     -       -       -       -  
Forfeited     (33,080 )     7.30       (241,484 )     -  
Unvested at June 30, 2025     693,929       7.21       5,001,916       3.36  
Granted     -       -       -       -  
Vested     (260,595 )     7.22       (1,882,417 )     -  
Forfeited     (44,180 )     7.30       (322,514 )     -  
Unvested at June 30, 2026     389,154     $ 7.19     $ 2,796,985       2.36  

 

As of June 30, 2026, there was $2,622,522 total unrecognized compensation cost related to unvested RSUs granted under the employee incentive plan. The total cost is expected to be recognized over a remaining period of 2.36 years. 

 

Warrants

 

In connection with the reverse recapitalization, each of 12,156,417 ACAC’s issued and outstanding warrants was converted automatically into one redeemable warrant of the Company, exercisable for one share of common stock of the Company at an exercise price of $11.50 per share. All of these warrants met the criteria for equity classification.

 

The Company may call the Warrants for redemption, in whole and not in part, at a price of $0.01 per Warrant:

 

  ● in whole and not in part;

 

  ● upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and

 

  ● if, and only if, the reported last sale price of the common stock equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.

 

The summary of warrants activity is as follows:

 

    Warrants
Outstanding
    Common
Stock
Issuable
    Weighted
Average
Exercise
Price
    Average
Remaining
Contractual
Life
 
June 30, 2024     -       -     $ -       -  
Granted     12,156,417       12,156,417     $ 11.50       5.00  
Forfeited     -       -     $ -       -  
Exercised     (10,500 )     (10,500 )   $ 11.50       -  
June 30, 2025     12,145,917       12,145,917     $ 11.50       4.24  
Granted     -       -     $ -       -  
Forfeited     -       -     $ -       -  
Exercised     -       -     $ -       -  
June 30, 2026     12,145,917       12,145,917     $ 11.50       3.24  

 

The Company accounted for the 12,145,917 Warrants assumed from the merger as equity instruments in accordance with ASC 480, Distinguishing Liabilities from Equity, and ASC 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity.  As of June 30, 2026 and 2025, the Warrants had no intrinsic value, as the Company’s stock price was below the strike price.

 

Cancellation of Common Stock Held in Escrow

 

On September 26, 2024 (issuance date), pursuant to the Business Combination Agreement, 500,000 shares were deposited to a segregated escrow account and would be release to the Old Foxx shareholders if and only if, prior to or upon the one-year anniversary of the Business Combination Agreement, the Affordable Connectivity Program managed by the U.S. Federal Communication Commission is reauthorized by the U.S. Congress with funding of no less than $4 billion in total for such reauthorized period; or otherwise be cancelled and forfeited by the Registrant without consideration.

 

On February 18, 2025, these 500,000 shares have been cancelled and forfeited without consideration.